This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2004 Jul 3;329(7456):31-4.

doi: 10.1136/bmj.329.7456.31.

Balancing benefits and harms: the example of non-steroidal anti-inflammatory drugs

Paul Dieppe¹, Christopher Bartlett, Peter Davey, Lesley Doyal, Shah Ebrahim

Affiliations

Affiliation

¹ Medical Research Council Health Services Research Collaboration, Department of Social Medicine, University of Bristol, Bristol BS8 2PR. p.dieppe@bristol.ac.uk

PMID: 15231619
PMCID: PMC443450
DOI: 10.1136/bmj.329.7456.31

Review

Balancing benefits and harms: the example of non-steroidal anti-inflammatory drugs

Paul Dieppe et al. BMJ. 2004.

. 2004 Jul 3;329(7456):31-4.

doi: 10.1136/bmj.329.7456.31.

Authors

Paul Dieppe¹, Christopher Bartlett, Peter Davey, Lesley Doyal, Shah Ebrahim

Affiliation

¹ Medical Research Council Health Services Research Collaboration, Department of Social Medicine, University of Bristol, Bristol BS8 2PR. p.dieppe@bristol.ac.uk

PMID: 15231619
PMCID: PMC443450
DOI: 10.1136/bmj.329.7456.31

No abstract available

PubMed Disclaimer

Figures

Figure 1
Pharmaceutical companies market new drugs from many angles Credit: MECKY/PHOTONICA

See this image and copyright information in PMC

Comment in

Balancing benefits and harms in health care: technology to collect and share information about harms already exists.
Cervi PL. Cervi PL. BMJ. 2004 Aug 21;329(7463):457; discussion 458-9. doi: 10.1136/bmj.329.7463.457. BMJ. 2004. PMID: 15321908 Free PMC article. No abstract available.
Balancing benefits and harms in health care: ethical dimension was not discussed in theme issue.
Ashcroft RE. Ashcroft RE. BMJ. 2004 Aug 21;329(7463):458; discussion 458-9. doi: 10.1136/bmj.329.7463.458. BMJ. 2004. PMID: 15321912 Free PMC article. No abstract available.

Similar articles

Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy.
Russell RI. Russell RI. Ital J Gastroenterol Hepatol. 1999;31 Suppl 1:S14-8. Ital J Gastroenterol Hepatol. 1999. PMID: 10379464 Review.
[Adverse effects of non-steroidal antirheumatic drugs with special reference to the gastrointestinal tract].
Hackenthal E. Hackenthal E. Z Rheumatol. 1987;46 Suppl 1:83-8. Z Rheumatol. 1987. PMID: 3439373 German. No abstract available.
Over-the-counter nonsteroidal anti-inflammatory drugs and risk of gastrointestinal symptoms.
Sangha S, Oviedo JA. Sangha S, et al. Am J Gastroenterol. 2003 May;98(5):1203-4; author reply 1204. doi: 10.1111/j.1572-0241.2003.07443.x. Am J Gastroenterol. 2003. PMID: 12809852 No abstract available.
Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
Chan FK, Graham DY. Chan FK, et al. Aliment Pharmacol Ther. 2004 May 15;19(10):1051-61. doi: 10.1111/j.1365-2036.2004.01935.x. Aliment Pharmacol Ther. 2004. PMID: 15142194 Review.
Cardiovascular safety of non-steroidal anti-inflammatory drugs among healthy individuals.
Fosbøl EL, Køber L, Torp-Pedersen C, Gislason GH. Fosbøl EL, et al. Expert Opin Drug Saf. 2010 Nov;9(6):893-903. doi: 10.1517/14740338.2010.501331. Expert Opin Drug Saf. 2010. PMID: 20569079 Review.

See all similar articles

Cited by

European Medicines Agency policies for clinical trials leave women unprotected.
Ruiz Cantero MT, Angeles Pardo M. Ruiz Cantero MT, et al. J Epidemiol Community Health. 2006 Nov;60(11):911-3. doi: 10.1136/jech.2006.048769. J Epidemiol Community Health. 2006. PMID: 17053276 Free PMC article.
Balancing benefits and harms in health care: technology to collect and share information about harms already exists.
Cervi PL. Cervi PL. BMJ. 2004 Aug 21;329(7463):457; discussion 458-9. doi: 10.1136/bmj.329.7463.457. BMJ. 2004. PMID: 15321908 Free PMC article. No abstract available.
Conducting separate reviews of benefits and harms could improve systematic reviews and meta-analyses.
Mayo-Wilson E, Qureshi R, Li T. Mayo-Wilson E, et al. Syst Rev. 2023 Apr 15;12(1):67. doi: 10.1186/s13643-023-02234-0. Syst Rev. 2023. PMID: 37061724 Free PMC article.
Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview.
Golder S, Loke YK, Bland M. Golder S, et al. PLoS Med. 2011 May;8(5):e1001026. doi: 10.1371/journal.pmed.1001026. Epub 2011 May 3. PLoS Med. 2011. PMID: 21559325 Free PMC article. Review.
Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis.
Zhang X, Donnan PT, Bell S, Guthrie B. Zhang X, et al. BMC Nephrol. 2017 Aug 1;18(1):256. doi: 10.1186/s12882-017-0673-8. BMC Nephrol. 2017. PMID: 28764659 Free PMC article.

See all "Cited by" articles

References

1. Lawrence R, Helmick CG, Arnett FC, Deyo RA, Felson DT, Gianni EH, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998;41: 778-99. - PubMed
1. Chard J, Tallon D, Dieppe P. Epidemiology of research into interventions for the treatment of osteoarthritis of the knee joint. Ann Rheum Dis 2000;59: 414-8. - PMC - PubMed
1. Evans JM, McDevitt DG, MacDonald TM. The Tayside Medicines Monitoring Unit (MEMO): a record-linkage system for pharmacovigilance. Pharmceut Med 2000;9: 177-84.
1. Bartlett C, Doyal L, Ebrahim S, Davey P, Bachmann M, Egger M, et al. The causes and effects of socio-demographic exclusions from clinical trials. Health Technol Assess Rep (in press). - PubMed
1. Bugeja G, Kumar A, Banarjee A. Exclusion of older people from clinical trials: a descriptive study of published reports. BMJ 1997;315: 1059. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources